Disease progression and survival following specific AIDS-defining conditions: A retrospective cohort study of 2048 HIV-infected persons in London

AIDS

Volumn 12, Issue 9, 1998, Pages 1007-1013

  Petruckevitch, Ann ^a   Del Amo, Julia ^a   Phillips, Andrew N ^b   Johnson, Anne M ^a   Stephenson, Judith ^a   Desmond, Noreen ^c   Hanscheid, Thomas ^d   Low, Nicola ^e   Newell, Anthony ^f   Obasi, Angela ^g   Paine, Katie ^e   Pym, Alexander ^h   Theodore, Cecilia ⁱ   De Cock, Kevin M ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

^c ST GEORGE S HOSPITAL   (United Kingdom)

^d LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^e KING S COLLEGE HOSPITAL   (United Kingdom)

^f CHELSEA AND WESTMINSTER HOSPITAL   (United Kingdom)

^g UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

^h ST MARY S HOSPITAL   (United Kingdom)

ⁱ CHARING CROSS HOSPITAL   (United Kingdom)

Author keywords

AIDS; London; Progression; Survival; Tuberculosis

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; COHORT ANALYSIS; DISEASE COURSE; ETHNIC GROUP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LYMPHOMA; MAJOR CLINICAL STUDY; NONHODGKIN LYMPHOMA; PNEUMOCYSTIS PNEUMONIA; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SURVIVAL; TUBERCULOSIS; UNITED KINGDOM;

EID: 7144254444     PISSN: 02699370     EISSN: None     Source Type: Journal    
DOI: 10.1097/00002030-199809000-00007     Document Type: Article

References (18)

1. Turner BJ, Markson LE, McKee L, Houchens R, Fanning T: The AIDS-defining diagnosis and subsequent complications: a survival-based severity index. J Acquir Immune Defic Syndr 1991, 4:1059-1071.
2. Mocroft A, Johnson MA, Sabin CA, et al.: Staging system for clinical AIDS patients. Lancet 1995, 346:12-17.
3. Mocroft A, Johnson MA, Phillips AN: Factors affecting survival in patients with the acquired immunodeficiency syndrome. AIDS 1996, 10:1057-1065.
4. Mellors JW, Kinsley LA, Rinaldo CRJ, et al.: Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995, 122:573-579.
5. Mellors JW, Rinaldo Jr CR, Gupta P, White RM, Todd JA, Kingsley LA: Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science 1996, 272:1167-1170 [Erratum, Science 1997, 275:14].
6. Mellors JW, Munoz A, Giorgi JV, et al.: Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997, 126:946-954.
7. Goletti D, Weissman D, Jackson RW, et al.: Effect of mycobacterium tuberculosis on HIV replication. J Immunol 1996, 157:1271-1278.
8. Whalen C, Horsburgh CR, Hom D, Lahart C, Simberkoff M, Ellner J: Accelerated course of human immunodeficiency virus infection after tuberculosis. Am J Resp Crit Care Med 1995, 151:129-135.
9. Perneger TV, Sudre P, Lundgren JD, Hirschel B for the AIDS in Europe Study Group: Does the onset of tuberculosis in AIDS predict shorter survival? Results of a cohort study in 17 European countries over 13 years. BMJ 1995, 311:1468-1471.
10. Del Amo J, Petruckevitch A, Phillips AN, et al.: Spectrum of disease in Africans with AIDS in London. AIDS 1996, 10:1563-1569.
11. Del Amo J, Petruckevitch A, Phillips AN, et al.: Disease progression and survival in HIV-infected Africans in London. AIDS 1998, 12 (in press).
12. Ancelle-Park R: Expanded European AIDS case definition [letter]. Lancet 1993, 341:441.
13. Centers for Disease Control: 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescence and adults. MMWR 1992, 41 (RR-17):1-19.
14. Lundgren JD, Pedersen C, Clumeck N, et al.: Survival differences in patients with AIDS, 1979-1989. BMJ 1994, 308:1068-1073.
15. Cayla JA, Artazcoz L, Iglesias B, et al.: The epidemiology of AIDS in Barcelona (1981-1991). II. A study of mortality and survival. Med Clin (Barc) 1994, 102:129-135.
16. Mocroft A, Youle M, Morcinek J, et al.: Survival after diagnosis of AIDS: a prospective observational study of 2625 patients. Royal Free/Chelsea and Westminster Hospitals Collaborative Group. BMJ 1997, 314:409-413.
17. Blum S, Singh TP, Gibbons J, et al.: Trends in survival among persons with acquired immunodeficiency syndrome in New York City. The experience of the first decade of the epidemic. Am J Epidemiol 1994, 139:351-361.
18. Ackah AN, Coulibaly D, Dybeu H, et al. Response to treatment, mortality and CD4 lymphocyte counts in HIV-infected persons with tuberculosis in Abidjan, Côte d'Ivoire. Lancet 1995, 345:607-610.